|
⚲
|
| Ascenta Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001483471 |
| Sale | 2010-01-25 ($15.0 M Offered, $1.8 M Sold) |
| Fund | |
| Phone | 6104080301 |
| Address | 101 Lindenwood Drive, Suite 405 Malvern, 19355 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Marc Lippman | |
| Andrew Senyei | |
| J Mel Sorensen | |
| Louis Bock | |
| Michael Powell | |
| Norman Selby | |
| Eckard Weber | |
| Joel Sussman |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
C/B Star Coinvest, L.P.
✚
|
0.0 | |
|
CC3 Investors LLC
✚
|
0.0 | |
|
CC4 Investors LLC
✚
|
0.0 | |
|
CC6 Investors LLC
✚
|
0.0 | |
|
CCA Bayview Investors, LP
✚
|
0.0 | |
|
CCA Life Settlements Fund II ICAV
✚
|
0.0 | |
|
CCAP Fund 6 - 2019, L.P.
✚
|
0.0 | |
|
CCAP Fund 8 - 2019, L.P.
✚
|
0.0 | |
|
CCC Headwaters at Autumn Hall LLC
✚
|
0.0 | |
|
C-Bridge Healthcare Fund V, L.P.
✚
|
0.0 |